Jane Doe v. Janssen Therapeutics
Opinion
NOT PRECEDENTIAL
UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT
No. 19-1376
UNITED STATES OF AMERICA; STATE OF CALIFORNIA;
STATE OF COLORADO; STATE OF CONNECTICUT; STATE OF DELAWARE;
STATE OF FLORIDA; STATE OF GEORGIA; STATE OF HAWAII; STATE OF ILLINOIS; STATE OF INDIANA; STATE OF IOWA; STATE OF LOUISIANA; STATE OF MARYLAND; STATE OF MONTANA; STATE OF NEVADA; STATE OF NEW HAMPSHIRE; STATE OF NEW JERSEY; STATE OF NEW MEXICO;
STATE OF NEW YORK; STATE OF NORTH CAROLINA;
STATE OF OKLAHOMA; STATE OF RHODE ISLAND; STATE OF TENNESSEE;
STATE OF TEXAS; STATE OF WASHINGTON; STATE OF WISCONSIN;
COMMONWEALTH OF VIRGINIA; and DISTRICT OF COLUMBIA ex rel. JANE AND JOHN DOE
v.
JANSSEN THERAPEUTICS, a division of Janssen Products, L.P., previously d/b/a Tibotec Therapeutics, division of Centocor Ortho Biotech Products, L.P.; JANSSEN PRODUCTS L.P., and; JOHNSON & JOHNSON, INC.
JANE DOE; JOHN DOE,
Appellants.
On Appeal from the United States District Court for the Eastern District of Pennsylvania (District Court No. 2-14-cv-06131)
District Judge: Honorable Nitza I. Quinones Alejandro
Argued on November 13, 2019 Before: JORDAN, SCIRICA and RENDELL, Circuit Judges
Christopher L. Nelson [Argued] The Weiser Law Firm 22 Cassatt Avenue Suite 100 Berwyn, PA 19312
Counsel for Appellant
Abigail A. Hazlett Michael A. Schwartz Pepper Hamilton Suite 3000 3000 Two Logan Square 18th and Arch Streets Philadelphia, PA 19103
Counsel for Appellee
O P I N I O N*
RENDELL, Circuit Judge:
Jane Doe and John Doe (the “Doe Relators”) filed a qui tam complaint (the “Original Complaint”) under seal and under their actual names against Janssen Therapeutics, Janssen Products, LP, and Johnson & Johnson, Inc. (“Defendants”) alleging that Defendants had submitted false claims to federal and state governments in relation to marketing and sales of one of Defendants’ pharmaceutical products. After the lawsuit proceeded for several years, the Doe Relators moved to amend the sealed Original Complaint to replace their real names with the pseudonyms John Doe and Jane
*
This disposition is not an opinion of the full Court and under I.O.P. 5.7 does not constitute binding precedent.
Doe. The District Court granted their motion and the Doe Relators filed the Amended Complaint. About a week later, the United States filed a notice of election to decline intervention, requested the Amended Complaint be unsealed, and requested the Original Complaint remain sealed. The District Court granted this relief. The Doe Relators then voluntarily dismissed their case. A year after the lawsuit was dismissed, Janssen Products, LP (“Janssen”) filed a motion to unseal the Original Complaint. The District Court, applying the standard for motions to proceed anonymously that we endorsed in Doe v. Megless, 654 F.3d 404 (3d Cir. 2011), granted Janssen’s motion.
We conclude that the applicable standard to Janssen’s motion is our standard for motions to seal or unseal judicial records. See In re Cendant Corp., 260 F.3d 183 (3d Cir. 2001). Accordingly, we will vacate the District Court’s judgment and remand to the District Court to evaluate Janssen’s motion under this standard.
I.1
The Doe Relators initiated this action by filing the Original Complaint under their actual names and under seal alleging that Defendants violated the False Claims Act, 31 U.S.C. § 3729, et seq., and analogous state statutes. The Doe Relators alleged that Defendants violated federal and state law by promoting off-label use of two HIV medications and submitting related false claims to the United States and state governments. No summonses were issued, and the Original Complaint was never served on any of the Defendants.
1 Because we write for the parties, who are familiar with the facts and the procedural posture to date, we only include what is necessary to explain our decision.
After the case proceeded under seal for more than two years, the Doe Relators were informed that they were not the first relators to file a qui tam lawsuit against Janssen stemming from the allegations in the Doe Relators’ Original Complaint. In response, the Doe Relators moved the District Court for leave to amend their Original Complaint. The District Court granted the Doe Relators’ motion for leave to amend, and the Doe Relators filed their Amended Complaint under seal shortly thereafter. The Amended Complaint was exactly the same as the Original Complaint with one exception: the Amended Complaint replaced each mention of the Doe Relators’ actual names with the pseudonyms Jane Doe or John Doe.
After the Amended Complaint had been filed, the United States filed a Notice of Election to Decline Intervention in which the government requested that the Amended Complaint and the Notice of Election to Decline Intervention be unsealed but that all other contents of the docket remain under seal. The District Court granted the government’s motion and the Amended Complaint was accordingly unsealed. The Original Complaint remained under seal. The Doe Relators subsequently voluntarily dismissed their suit.
A year after the Doe Relators’ qui tam lawsuit was dismissed, Janssen filed a motion in the case asking the District Court to unseal the Original Complaint. The District Court granted the motion in a sealed seven-page memorandum opinion. The District Court ruled that our opinion in Doe v. Megless, 654 F.3d 404 (3d Cir. 2011), governed Janssen’s motion, and that the Megless test favored unsealing the Doe Relators’
Original Complaint.2 The District Court ordered that the Original Complaint remain under seal for forty-five days. Before the Original Complaint was unsealed, the Doe Relators timely appealed.
II.3
“We review de novo a legal standard applied by a district court.” Neale v. Volvo Cars of N. Am., LLC, 794 F.3d 353, 358 (3d Cir. 2015) (quoting Carrera v. Bayer Corp., 727 F.3d 300, 305 (3d Cir. 2013)).
III.
A. In re Cendant Corp. applies to Janssen’s motion to unseal the Original Complaint.
The Doe Relators argue that the Megless standard does not apply to Janssen’s motion to unseal the Original Complaint. We agree.
1. The Megless and In re Cendant Corp. Standards In Doe v. Megless, we set out the test—applied by the District Court in this case—
that applies when a litigant moves to proceed anonymously, usually under a pseudonym. Megless, 654 F.3d at 408. We noted that, to prevail on such a motion, “a plaintiff must show ‘both (1) a fear of severe harm, and (2) that the fear of severe harm is reasonable.’” Id. (quoting Doe v. Kamehameha Schs./Bernice Pauahi Bishop Estate, 596 F.3d 1036, 1043 (9th Cir. 2010)). We further indicated that once a litigant makes this initial
2 We do not discuss the District Court’s factfinding or analysis because the District Court’s memorandum was filed under seal and remains under seal. 3 The District Court had jurisdiction under 31 U.S.C. § 3732. We have jurisdiction under 28 U.S.C. § 1291. See, e.g., Leucadia, Inc. v. Applied Extrusion Techs., Inc., 998 F.2d 157, 160–61 (3d Cir. 1993).
showing, “district courts should balance a plaintiff’s interest and fear against the public’s strong interest in an open litigation process.” Id. In this balancing test, there are several factors that would favor the grant of anonymity and several that would disfavor it.4 When a litigant instead moves to seal or unseal judicial records, we instruct district courts to apply a different standard. In In re Avandia Marketing, Sales Practices & Products Liability Litigation, 924 F.3d 662 (3d Cir. 2019), we noted that “a common law right of access attaches to judicial proceedings and records” and encompasses “the right to . . . inspect and copy public records and documents, including judicial records and documents.” In re Avandia, 924 F.3d at 672 (internal quotation marks and citations
4 The factors that weigh in favor of anonymity include but are not limited to:
(1) the extent to which the identity of the litigant has been kept confidential;
Free access — add to your briefcase to read the full text and ask questions with AI
Jane Doe v. Janssen Therapeutics (Jane Doe v. Janssen Therapeutics) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.